Catheters Global Market - Forecast to 2022

Publishing Date : March, 2016
Report Code : HCMD 0110
Price:
Single license $4,500
Site license $6,300
Global license $9,000


Note: The report would be dispatched after confirmation of payment

Catheter is a tubular medical device introduced into different body canals, vessels, passage ways and cavities for diagnostic or therapeutic purposes. These catheters are made of different types of polymers and inert materials, and are coated with antimicrobial and special substances to avoid infections and other complications. The catheters are used in various medical fields such as neurovascular, cardiovascular, urology and other specialty segments like nephrology, gynecology, and gastroenterology.

Catheters market is segmented on the basis of product type, materials, end-users and geography. Product type is further segmented into cardiovascular, neurovascular, urinary, intravenous, specialities. The cardiovascular segment is further subsegmented into electrophysiology catheters, balloon catheters, guiding catheters, pulmonary artery catheters, and intravascular ultrasound catheters. Neurovascular catheters are further classified into micro catheters, neuro thrombectomy catheters and neuro embolization catheters. Urinary catheters are segmented into intermittent (temporary) catheters, foley (indwelling) catheters and male external catheters. Intravenous catheters include peripheral catheters, central venous catheters, similarly specialty catheters are segmented into wound/surgical drain catheters, oximetry catheters, thermodilution catheters, gastroenterology catheters, gynaecology catheters and dialysis Catheters.

Based on materials the catheters market is segmented into silicone, polyurethane, polyethylene, teflon/ PTFE and others. End-users are segmented into hospitals, diagnostic laboratories, academic and research laboratories, ambulatory surgical centers, home healthcare providers.

Among the catheters products, the cardiovascular catheter market dominates the products market by occupying a largest share of 33.7%.  At the same time, specialty catheters market is the fastest growing segment with a high single digit CAGR from 2015 to 2022. In materials, the silicone is the largest segment with 28.8% share and polyethylene are the fastest growing segment with a high single digit CAGR from 2015 to 2022. In end- users, hospitals are the largest segment as well as fastest growing segment from 2015 to 2022. Geographically, North America is the largest market, followed by Europe and Asia. The APAC region is the fastest growing region with a double digit CAGR from 2015 to 2022 presenting an array of opportunities for growth and is likely to get attention of new investors in the catheters market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.

The catheters market is expected to grow steadily at a CAGR of XX% during 2015 to 2022. Increased life expectancy and combined with rise in aging population, growing prevalence of cardiovascular diseases, diabetes and urinary diseases, growing healthcare expenditures in developing countries and trend towards the use of single use catheters and self catheterization are the factors driving the market growth. Adoption of minimally invasive procedures, growing advent of technological advancements pertaining to catheter materials that prevent biofilm formation and developing nations like India and China catheters market are expected to offer potential opportunities.

Similarly various factors like increasing rate of Catheter Assisted-Urinary Tract Infection (CA-UTI) associated with healthcare acquired infections, high cost involved in cardiac and neurological procedures and lack of experienced and skilled professionals limit the growth of catheters global market. The threats for the catheters market include increase in pricing pressure on market players and stringent regulatory bodies.

The catheters global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the catheters market are Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), Johnson & Johnson (U.S.), B.Braun Melsungen AG (Germany), Beckton Dickinson (U.S.), C.R.Bard (U.S.), ColoPlast (Denmark), Angio Dynamics (U.S.), St. Jude Medical (U.S.) and Philips (Netherlands).

The report provides an in depth market analysis of the above mentioned segments across the following regions:

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)
  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKE AWAYS
    • 2.2     REPORT DESCRIPTION
    • 2.3     MARKETS COVERED
    • 2.4     STAKEHOLDERS
    • 2.5     RESEARCH METHODOLOGY
      • 2.5.1     MARKET SIZE ESTIMATION
      • 2.5.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.5.3     SECONDARY SOURCES
      • 2.5.4     PRIMARY SOURCES
      • 2.5.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.5.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.5.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS & OPPORTUNITIES
        • 3.3.1.1     INCREASING LIFE EXPECTANCY COMBINED WITH RISE IN AGING POPULATION
        • 3.3.1.2     GROWING PREVALENCE OF CARDIOVASCULAR DISEASES, DIABETES AND URINARY DISEASES
        • 3.3.1.3     GROWING HEALTHCARE BUDGETARY ALLOCATION IN DEVELOPING COUNTRIES
        • 3.3.1.4     TRENDS TOWARDS SINGLE USE CATHETERS AND SELF CATHETERIZATION
        • 3.3.1.5     EMERGING ECONOMIES LIKE INDIA AND CHINA CATHETERS MARKET ARE EXPECTED TO OFFER POTENTIAL OPPORTUNITIES
        • 3.3.1.6     ADOPTION OF MINIMALLY INVASIVE PROCEDURES
        • 3.3.1.7     TECHNOLOGICAL ADVANCEMENTS PERTAINING TO CATHETERS MATERIALS THAT PREVENT BIOFILM FORMATION
      • 3.3.2     RESTRAINTS & THREATS
        • 3.3.2.1     INCREASING INCIDENCES OF ACQUIRED INFECTIONS DUE TO BIOFILM FORMATION DURING USE OF LONG TERM INDWELLING CATHETERS
        • 3.3.2.2     HIGH COST INVOLVED IN CARDIAC AND NEUROLOGICAL PROCEDURES
        • 3.3.2.3     LACK OF EXPERIENCED AND SKILLED PROFESSIONAL TO HANDLE THE CATHETERS INSERTION PROCEDURE
        • 3.3.2.4     INCREASE IN PRICING PRESSURE ON MARKET PLAYERS
        • 3.3.2.5     STRINGENT REGULATORY BODIES
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     U.S.
      • 3.4.2     EUROPE
      • 3.4.3     CHINA
      • 3.4.4     INDIA
      • 3.4.5     JAPAN
    • 3.5     REIMBURSEMENT SCENARIO
      • 3.5.1     REIMBURSEMENT TABLE
    • 3.6     TECHNOLOGICAL ADVANCEMENTS AND UPCOMING TECHNOLOGIES & PRODUCT LAUNCHES
      • 3.6.1     CATHETER BASED IMAGING DEVICES (IMAGING CATHETERS)
      • 3.6.2     CATH LAB
      • 3.6.3     ROBOTIC CATHETERS
      • 3.6.4     3D PRINTED & CUSTOM CATHETERS
      • 3.6.5     SPRAY CATHETERS
      • 3.6.6     LASER FIBER CATHETERS
      • 3.6.7     SINGLE USE REPROCESSED CATHETERS
      • 3.6.8     TECHNOLOGIES UNDER CLINICAL TRIAL
      • 3.6.9     RECENT AND UPCOMING PRODUCT LAUNCHES
    • 3.7     COATINGS FOR CATHETERS
    • 3.8     PORTER'S FIVE FORCE ANALYSIS
      • 3.8.1     THREAT OF NEW ENTRANTS
      • 3.8.2     THREAT OF SUBSTITUTES
      • 3.8.3     RIVALRY AMONG EXISTING COMPETITORS
      • 3.8.4     BARGAINING POWER OF SUPPLIERS
      • 3.8.5     BARGAINING POWER OF BUYERS
    • 3.9     SUPPLY CHAIN ANALYSIS
    • 3.10     PATENT ANALYSIS
    • 3.11     MARKET SHARE ANALYSIS
  • 4     CATHETERS GLOBAL MARKET, BY PRODUCT TYPE
    • 4.1     INTRODUCTION
    • 4.2     CARDIAC CATHETERS
      • 4.2.1     BALLOON CATHETERS
        • 4.2.1.1     ANGIOGRAPHY BALLOON CATHETERS
        • 4.2.1.2     ANGIOPLASTY BALLOON CATHETERS
          • 4.2.1.2.1     PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOON CATHETERS
          • 4.2.1.2.2     PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS
      • 4.2.2     ELECTROPHYSIOLOGY CATHETERS
        • 4.2.2.1     DIAGNOSTIC ELECTROPHYSIOLOGY CATHETERS
        • 4.2.2.2     ABLATION ELECTROPHYSIOLOGY CATHETERS
      • 4.2.3     GUIDING CATHETERS
      • 4.2.4     PULMONARY ARTERY CATHETERS
      • 4.2.5     INTRAVASCULAR ULTRASOUND CATHETERS
    • 4.3     URINARY CATHETERS
      • 4.3.1     INTERMITTENT (TEMPORARY OR SHORT-TERM) CATHETERS
      • 4.3.2     FOLEY (INDWELLING OR SUPRAPUBIC) CATHETERS
      • 4.3.3     MALE EXTERNAL CATHETERS (CONDOM CATHETERS)
    • 4.4     NEUROVASCULAR CATHETERS
      • 4.4.1     MICRO CATHETERS
      • 4.4.2     NEURO THROMBECTOMY CATHETERS
      • 4.4.3     NEURO EMBOLIZATION CATHETERS
    • 4.5     INTRAVENOUS CATHETERS
      • 4.5.1     PERIPHERAL CATHETERS
        • 4.5.1.1     MIDLINE PERIPHERAL CATHETERS
      • 4.5.2     CENTRAL VENOUS CATHETERS
        • 4.5.2.1     PERIPHERALLY INSERTED CENTRAL CATHETERS (PICC)
        • 4.5.2.2     CENTRAL VENOUS CATHETER
        • 4.5.2.3     NON-TUNNELED EXTERNAL CATHETER
        • 4.5.2.4     TUNNELED EXTERNAL CATHETER
    • 4.6     SPECIALTY CATHETER
      • 4.6.1     WOUND/SURGICAL DRAIN CATHETERS
      • 4.6.2     OXIMETRY CATHETERS
      • 4.6.3     THERMODILUTION CATHETERS
      • 4.6.4     DIALYSIS CATHETERS
      • 4.6.5     GYNAECOLOGY CATHETERS
      • 4.6.6     GASTROENTEROLOGY CATHETER
  • 5     CATHETERS GLOBAL MARKET, BY MATERIALS
    • 5.1     INTRODUCTION
    • 5.2     CATHETERS MATERIAL COMPARISON
    • 5.3     SILICONE CATHETERS
    • 5.4     POLYURETHANE CATHETERS
    • 5.5     POLYETHYLENE CATHETERS
    • 5.6     TEFLON/PTFE CATHETERS
    • 5.7     OTHERS (NITINOL, NYLON) CATHETERS
  • 6     CATHETERS GLOBAL MARKET, BY END-USERS
    • 6.1     INTRODUCTION
    • 6.2     HOSPITALS
    • 6.3     AMBULATORY SURGICAL CENTERS
    • 6.4     DIAGNOSTIC LABORATORIES
    • 6.5     ACADEMIC RESEARCH LABORATORIES
    • 6.6     HOME HEALTHCARE PROVIDERS
  • 7     REGIONAL ANALYSIS
    • 7.1     INTRODUCTION
    • 7.2     NORTH AMERICA
    • 7.3     EUROPE
    • 7.4     ASIA PACIFIC
      • 7.4.1     INDIA
      • 7.4.2     CHINA
    • 7.5     REST OF THE WORLD
  • 8     COMPANY DEVELOPMENTS
    • 8.1     INTRODUCTION
    • 8.2     APPROVALS
    • 8.3     ACQUISITIONS & COLLABORATIONS
    • 8.4     NEW PRODUCT LAUNCHES
    • 8.5     AGREEMENTS & EXPANSION
  • 9     COMPANY PROFILES
    • 9.1     ABBOTT LABORATORIES
      • 9.1.1     OVERVIEW
      • 9.1.2     FINANCIALS
      • 9.1.3     PRODUCT PORTFOLIO
      • 9.1.4     KEY DEVELOPMENTS
      • 9.1.5     BUSINESS STRATEGY
      • 9.1.6     SWOT ANALYSIS
    • 9.2     ANGIODYNAMICS INC.
      • 9.2.1     OVERVIEW
      • 9.2.2     FINANCIALS
      • 9.2.3     PRODUCT PORTFOLIO
      • 9.2.4     KEY DEVELOPMENTS
      • 9.2.5     BUSINESS STRATEGY
      • 9.2.6     SWOT ANALYSIS
    • 9.3     B. BRAUN MELSUNGEN AG
      • 9.3.1     OVERVIEW
      • 9.3.2     FINANCIALS
      • 9.3.3     PRODUCT PORTFOLIO
      • 9.3.4     KEY DEVELOPMENTS
      • 9.3.5     BUSINESS STRATEGY
      • 9.3.6     SWOT ANALYSIS
    • 9.4     BECTON, DICKINSON AND COMPANY
      • 9.4.1     OVERVIEW
      • 9.4.2     FINANCIALS
      • 9.4.3     PRODUCT PORTFOLIO
      • 9.4.4     KEY DEVELOPMENTS
      • 9.4.5     BUSINESS STRATEGY
      • 9.4.6     SWOT ANALYSIS
    • 9.5     BOSTON SCIENTIFIC CORPORATION
      • 9.5.1     OVERVIEW
      • 9.5.2     FINANCIALS
      • 9.5.3     PRODUCT PORTFOLIO
      • 9.5.4     KEY DEVELOPMENTS
      • 9.5.5     BUSINESS STRATEGY
      • 9.5.6     SWOT ANALYSIS
    • 9.6     C.R.BARD, INC.
      • 9.6.1     OVERVIEW
      • 9.6.2     FINANCIALS
      • 9.6.3     PRODUCT PORTFOLIO
      • 9.6.4     KEY DEVELOPMENTS
      • 9.6.5     BUSINESS STRATEGY
      • 9.6.6     SWOT ANALYSIS
    • 9.7     COLOPLAST
      • 9.7.1     OVERVIEW
      • 9.7.2     FINANCIALS
      • 9.7.3     PRODUCT PORTFOLIO
      • 9.7.4     KEY DEVELOPMENTS
      • 9.7.5     BUSINESS STRATEGY
      • 9.7.6     SWOT ANALYSIS
    • 9.8     JOHNSON & JOHNSON
      • 9.8.1     OVERVIEW
      • 9.8.2     FINANCIALS
      • 9.8.3     PRODUCT PORTFOLIO
      • 9.8.4     KEY DEVELOPMENTS
      • 9.8.5     BUSINESS STRATEGY
      • 9.8.6     SWOT ANALYSIS
    • 9.9     PHILIPS HEALTHCARE
      • 9.9.1     OVERVIEW
      • 9.9.2     FINANCIALS
      • 9.9.3     PRODUCT PORTFOLIO
      • 9.9.4     KEY DEVELOPMENTS
      • 9.9.5     BUSINESS STRATEGY
      • 9.9.6     SWOT ANALYSIS
    • 9.10     ST JUDE MEDICAL, INC
      • 9.10.1     OVERVIEW
      • 9.10.2     FINANCIALS
      • 9.10.3     PRODUCT PORTFOLIO
      • 9.10.4     KEY DEVELOPMENTS
      • 9.10.5     BUSINESS STRATEGY
      • 9.10.6     SWOT ANALYSIS
    • 9.11     TELEFLEX INCORPORATED
      • 9.11.1     OVERVIEW
      • 9.11.2     FINANCIALS
      • 9.11.3     PRODUCT PORTFOLIO
      • 9.11.4     KEY DEVELOPMENTS
      • 9.11.5     BUSINESS STRATEGY
      • 9.11.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 2     CATHETERS GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2014-2022) ($MN)
      • TABLE 3     CARDIOVASCULAR CATHETERS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 4     CARDIOVASCULAR CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 5     BALLOON CATHETERS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 6     ANGIOGRAPHY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 7     ANGIOPLASTY CATHETERS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 8     ANGIOPLASTY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 9     PTCA (PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY) BALLOON CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 10     PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY) BALLOON CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 11     ELECTROPHYSIOLOGY CATHETERS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 12     ELECTROPHYSIOLOGY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 13     DIAGNOSTIC ELECTROPHYSIOLOGY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 14     ABLATION ELECTROPHYSIOLOGY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 15     GUIDING CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 16     PULMONARY ARTERY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 17     INTRAVASCULAR ULTRASOUND CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 18     URINARY CATHETERS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 19     URINARY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 20     INTERMITTENT (TEMPERORY) CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 21     FOLEY (INDWELLING) CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 22     MALE EXTERNAL CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 23     NEUROVASCULAR CATHETERS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 24     NEUROVASCULAR CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 25     MICRO CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 26     NEURO THROMBECTOMY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 27     NEURO EMBOLIZATION CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 28     INTRAVENOUS CATHETERS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 29     INTRAVASCULAR CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 30     PERIPHERAL CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 31     CENTRAL VENOUS CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 32     CENTRAL VENOUS CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 33     PICC GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 34     CVC GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 35     NON-TUNNELED EXTERNAL CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 36     TUNNELED EXTERNAL CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 37     SPECIALTY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 38     SPECIALTY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 39     WOUND/SURGICAL DRAIN CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 40     OXIMETRY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 41     THERMODILUTION CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 42     DIALYSIS CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 43     GYNAECOLOGY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 44     GASTROENTEROLOGY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 45     CATHETERS GLOBAL MARKET REVENUE, BY MATERIALS, (2014-2022) ($MN)
      • TABLE 46     SILICONE CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 47     POLYURETHANE CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 48     POLYETHYLENE CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 49     TEFLON/PTFE CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 50     OTHER CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 51     CATHETERS GLOBAL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
      • TABLE 52     HOSPITALS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 53     AMBULATORY SURGICAL CENTRES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 54     DIAGNOSTIC LABORATORIES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 55     ACADEMIC & RESEARCH LABORATORIES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 56     HOME HEALTHCARE PROVIDERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 57     NORTH AMERICAN CATHETERS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
      • TABLE 58     NORTH AMERICAN CARDIOVASCULAR CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 59     NORTH AMERICAN ELECTROPHYSIOLOGY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 60     NORTH AMERIAN BALLOON CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 61     NORTH AMERICAN ANGIOPLASTY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 62     NORTH AMERICAN NEUROVASCULAR CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 63     NORTH AMERICAN URINARY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 64     NORTH AMERICAN INTRAVENOUS CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 65     NORTH AMERICAN CENTRAL VENOUS CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 66     NORTH AMERICAN SPECIALTY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 67     NORTH AMERICAN CATHETERS MARKET REVENUE, BY MATERIAL, (2014-2022) ($MN)
      • TABLE 68     NORTH AMERICAN CATHETERS MARKET REVENUE, BY END-USER, (2014-2022) ($MN)
      • TABLE 69     EUROPEAN CATHETERS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
      • TABLE 70     EUROPEAN CARDIOVASCULAR CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 71     EUROPEAN ELECTROPHYSIOLOGY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 72     EUROPEAN BALLOON CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 73     EUROPEAN ANGIOPLASTY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 74     EUROPEAN NEUROVASCULAR CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 75     EUROPEAN URINARY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 76     EUROPEAN INTRAVENOUS CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 77     EUROPEAN CENTRAL VENOUS CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 78     EUROPEAN SPECIALTY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 79     EUROPEAN CATHETERS MARKET REVENUE, BY MATERIAL, (2014-2022) ($MN)
      • TABLE 80     EUROPEAN CATHETERS MARKET REVENUE, BY END-USER, (2014-2022) ($MN)
      • TABLE 81     ASIA PACIFIC CATHETERS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
      • TABLE 82     ASIA PACIFIC CARDIOVASCULAR CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 83     ASIA PACIFIC ELECTROPHYSIOLOGY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 84     ASIA PACIFIC BALLOON CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 85     ASIA PACIFIC ANGIOPLASTY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 86     ASIA PACIFIC NEUROVASCULAR CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 87     ASIA PACIFIC URINARY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 88     ASIA PACIFIC INTRAVENOUS CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 89     ASIA PACIFIC CENTRAL VENOUS CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 90     ASIA PACIFIC SPECIALTY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 91     ASIA PACIFIC CATHETERS MARKET REVENUE, BY MATERIAL, (2014-2022) ($MN)
      • TABLE 92     ASIA PACIFIC CATHETERS MARKET REVENUE, BY END-USER, (2014-2022) ($MN)
      • TABLE 93     ROW CATHETERS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
      • TABLE 94     ROW CARDIOVASCULAR CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 95     ROW ELECTROPHYSIOLOGY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 96     ROW BALLOON CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 97     ROW ANGIOPLASTY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 98     ROW NEUROVASCULAR CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 99     ROW URINARY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 100     ROW INTRAVENOUS CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 101     ROW CENTRAL VENOUS CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 102     ROW SPECIALTY CATHETERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 103     ROW CATHETERS MARKET REVENUE, BY MATERIAL, (2014-2022) ($MN)
      • TABLE 104     ROW CATHETERS MARKET REVENUE, BY END-USER, (2014-2022) ($MN)
      • TABLE 105     APPROVALS (2013-2015)
      • TABLE 106     ACQUISTIONS & COLLABORATIONS (2013-2015)
      • TABLE 107     NEW PRODUCT LAUNCHES (2013-2015)
      • TABLE 108     AGREEMENTS & EXPANSION (2013-2015)
      • TABLE 109     ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 110     ABBOTT LABORATORIES: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 111     ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 112     ANGIODYNAMICS INC.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 113     ANGIODYNAMICS INC.: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 114     ANGIODYNAMICS INC.: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 115     B.BRAUN MELSUNGEN AG: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN)
      • TABLE 116     B.BRAUN MELSUNGEN AG: TOTAL REVENUE, BY SEGMENT, (2012-2014) ($MN)
      • TABLE 117     B.BRAUN MELSUNGEN AG: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN)
      • TABLE 118     BECTON, DICKINSON AND COMPANY : TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 119     BECTON, DICKINSON AND COMPANY : TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 120     BECTON, DICKINSON AND COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($ MN)
      • TABLE 121     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 122     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2013-15) ($MN)
      • TABLE 123     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 124     C.R.BARD INC.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 125     C.R.BARD INC: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 126     COLOPLAST: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 127     COLOPLAST: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 128     COLOPLAST: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 129     JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 130     JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 131     JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 132     PHILIPS N.V.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 133     PHILIPS N.V.: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 134     PHILIPS HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 135     ST JUDE MEDICAL: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 136     ST JUDE MEDICAL : TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 137     ST.JUDE MEDICAL: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 138     TELEFLEX INCORPORATED.: TOTAL SALES AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 139     TELEFLEX INCORPORATED: TOTAL SALES, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 140     TELEFLEX INCORPORATED: TOTAL SALES, BY GEOGRAPHY, (2013-2015) ($MN)

      LIST OF FIGURES

      • FIGURE 1     CATHETERS GLOBAL MARKET REVENUE, BY REGION (2014-2022)
      • FIGURE 2     CATHETERS GLOBAL MARKET: RESEARCH APPROACH
      • FIGURE 3     CATHETERS GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     CATHETERS GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     CATHETERS GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
      • FIGURE 6     CATHETER GLOBAL MARKET: MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     CATHETERS GLOBAL MARKET: PORTER'S ANALYSIS
      • FIGURE 9     CATHETERS MARKET:PATENT FILING BY MAJOR PLAYERS (2011-2016)
      • FIGURE 10     CATHETERS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015
      • FIGURE 11     CATHETERS GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2015 V'S 2022) ($MN)
      • FIGURE 12     CARDIOVASCULAR CATHETERS GLOBAL MARKET REVENUE, BY TYPE, (2015 V'S 2022) ($MN)
      • FIGURE 13     URINARY CATHETERS MARKET REVENUE, BY TYPE, (2015 V'S 2022) ($MN)
      • FIGURE 14     NEUROVASCULAR CATHETERS GLOBAL MARKET REVENUE, BY TYPE, (2015 V'S 2022) ($MN)
      • FIGURE 15     INTRAVENOUS CATHETER GLOBAL MARKET REVENUE, BY TYPE, (2015 V'S 2022) ($MN)
      • FIGURE 16     SPECIALTY CATHETER GLOBAL MARKET REVENUE, BY TYPE, (2015 V'S 2022) ($MN)
      • FIGURE 17     CATHETER GLOBAL MARKET REVENUE, BY MATERIAL, (2015 V'S 2022) ($MN)
      • FIGURE 18     CATHETER GLOBAL MARKET REVENUE, BY END-USERS, (2015 V'S 2022) ($MN)
      • FIGURE 19     CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • FIGURE 20     NORTH AMERICAN CATHETERS MARKET SIZE, BY PRODUCT, MATERIAL, & END-USER OUTLOOK, (2015 V'S 2022) ($MN)
      • FIGURE 21     EUROPEAN CATHETERS MARKET SIZE, BY PRODUCTS, MATERIALS & END-USER OUTLOOK, (2015 V'S 2022) ($MN)
      • FIGURE 22     ASIA-PACIFIC CATHETERS MARKET SIZE, BY PRODUCT, MATERIAL & END-USER OUTLOOK, (2015 V'S 2022) ($MN)
      • FIGURE 23     ROW CATHETERS MARKET SIZE, BY PRODUCT, MATERIAL & END-USER OUTLOOK, (2015 V'S 2022) ($MN)
      • FIGURE 24     KEY GROWTH STRATEGIES, (2013-2015)
      • FIGURE 25     SWOT: ABBOTT LABORATORIES
      • FIGURE 26     SWOT: ANGIODYNAMICS, INC.
      • FIGURE 27     SWOT: B.BRAUN MELSUNGEN AG
      • FIGURE 28     SWOT: BECTON DICKINSON & COMPANY
      • FIGURE 29     SWOT: BOSTON SCIENTIFIC CORPORATION
      • FIGURE 30     SWOT: C.R.BARD INC.
      • FIGURE 31     SWOT: COLOPLAST
      • FIGURE 32     SWOT: JOHNSON & JOHNSON
      • FIGURE 33     SWOT: PHILIPS HEALTHCARE
      • FIGURE 34     SWOT: ST.JUDE MEDICAL
      • FIGURE 35     SWOT: TELEFLEX INCORPORATED

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     Abbott Laboratories
      • 2     Access Point Technologies
      • 3     ACIST Medical Systems, Inc.
      • 4     Acura
      • 5     Acutus Medical
      • 6     Advanced Cath
      • 7     Advanced Cath
      • 8     Aknor Medical
      • 9     All Pro Oxygen Catheter Co, Ltd
      • 10     Alpha Medical
      • 11     AmeCath
      • 12     Ameco Medical Industries
      • 13     AngioDynamics, Inc.
      • 14     Angioscore
      • 15     Apexmed International
      • 16     Argon Medical Devices
      • 17     ArraVasc
      • 18     Asid Bonz
      • 19     Aspen surgical
      • 20     AtriCurte Corporate
      • 21     Atrium Medical
      • 22     Avenu Medical
      • 23     B.Braun Melsungen AG
      • 24     Bactiguard
      • 25     Becton Dickinson and Company
      • 26     BioDerm, Inc.
      • 27     Biomerics
      • 28     Biosense Webster, Inc
      • 29     Biosensors International Ltd
      • 30     Biotronik
      • 31     Boston Scientific Corporation
      • 32     Bound Tree Medical
      • 33     Brazil Cor
      • 34     Brosmed
      • 35     BSN medical GmbH
      • 36     C.R. Bard
      • 37     Candis
      • 38     CardioMed
      • 39     Cardionovum
      • 40     ChileCom Medical Devices Co, Ltd
      • 41     Claret Medical
      • 42     ClearStream
      • 43     Codman Neuro
      • 44     Coloplast
      • 45     Compact Cath
      • 46     Concentric Medical
      • 47     ConvoTec
      • 48     Cook Medical
      • 49     Cordis Corporation
      • 50     Creganna Medical
      • 51     Cure Medical
      • 52     De Royal
      • 53     Degania Medical
      • 54     Dentsleeve
      • 55     Depuy Synthes
      • 56     Dynarex
      • 57     Edline
      • 58     Edwards Lifescience Corporation
      • 59     Endo-Flex GmbH
      • 60     EP MedSystems
      • 61     Fannin
      • 62     Frank Healthcare Co. Ltd
      • 63     Fresenius Medical Care AG & Co. KGaA
      • 64     Galt Medical
      • 65     Gambro
      • 66     Greatbatch Medical
      • 67     Gynotec
      • 68     Hagmed
      • 69     Hansen Medical
      • 70     Health Line International Corporation
      • 71     Hollister Co
      • 72     Hunter Urology
      • 73      ICU Medical
      • 74     Jiangsu Ealontech Medical Co, Ltd
      • 75     Johnson & Johnson
      • 76     Kimal PLC
      • 77     LeoMed
      • 78     LEPU Medical
      • 79     Life Science Co,
      • 80     Lifeline Medical
      • 81     Manfred Sauer GmbH
      • 82     MAQUET
      • 83     MARTECH Medical
      • 84     Mayo health care
      • 85     MDMI Manufacturing Canada Ltd
      • 86     MedComp
      • 87     MediPlus Ltd
      • 88     Meditech Lab
      • 89     Medivators
      • 90     Medline
      • 91     Medtronic Plc
      • 92     Merit Medical Systems
      • 93     Messe Dusseldorf GmbH
      • 94     Microport
      • 95     MinVASYS
      • 96     MMS Medical
      • 97     NATEC Medical
      • 98     Navilyst
      • 99     Nipro
      • 100     Olympus
      • 101     Optimed
      • 102     Origo
      • 103     OSCOR, Inc.
      • 104     PanMed
      • 105     Pennine Healthcare
      • 106     Penumbra, Inc.
      • 107     pfm medical ag
      • 108     Philips
      • 109     Poiesis Medical
      • 110     QT Vascular
      • 111     Quasar Engineering Ltd
      • 112     Redax
      • 113     Relisys Medical Devices Limited
      • 114     Reverse Medical
      • 115     Romsons International
      • 116     Rontis AG
      • 117     Roxwood Medical, Inc.
      • 118     Scitech Productos Medicos Ltda
      • 119     Shangai Neo-Medical Co Ltd
      • 120     Shanghai Microport Medical Co,
      • 121     Siemens AG
      • 122     Smiths Medical
      • 123     Solomon Scientific
      • 124     SomaTex Medical Technologies
      • 125     Spectranetics Corporation
      • 126     St.Jude Medical
      • 127     Star Medical
      • 128     Sterimed Surgicals India Pvt Ltd
      • 129     Stryker
      • 130     Surfire Medical, Inc.
      • 131     Suru International Pvt, Ltd
      • 132     Tangent Medical Technologies
      • 133     Teleflex Incorporated
      • 134     Terumo
      • 135     Theragenics
      • 136     Thomas Medical
      • 137     Triple Ring Technologies
      • 138     Uro Technology Sdn Bhd
      • 139     UroTec GmbH
      • 140     Utah Medical
      • 141     Utah Medical Products Inc.
      • 142     Vascular Solutions, Inc.
      • 143     Volcano Corporation
      • 144     Vygon
      • 145     WellMed International Industries Pvt Ltd